by Truveta Staff | Oct 2, 2023 | Technology
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...
by Truveta Staff | Aug 22, 2023 | Technology
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Lisa Gurry, Chief Growth Officer | Jul 31, 2023 | Technology
Rare diseases as a category aren’t that rare if you consider they impact 30 million Americans and 400 million people around the world. Not to mention their families, who often become caregivers. Yet, with nearly 7,000 rare diseases (identified as of today…), each is...
